Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion.
about
Type II transmembrane serine proteases as potential targets for cancer therapy.The role of type II transmembrane serine protease-mediated signaling in cancer.The serine proteinase hepsin is an activator of pro-matrix metalloproteinases: molecular mechanisms and implications for extracellular matrix turnover.Analyzing the Type II Transmembrane Serine Protease Hepsin-Dependent Basement Membrane Remodeling in 3D Cell Culture.Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein.
P2860
Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Deregulated hepsin protease ac ...... isrupting epithelial cohesion.
@en
Deregulated hepsin protease ac ...... isrupting epithelial cohesion.
@nl
type
label
Deregulated hepsin protease ac ...... isrupting epithelial cohesion.
@en
Deregulated hepsin protease ac ...... isrupting epithelial cohesion.
@nl
prefLabel
Deregulated hepsin protease ac ...... isrupting epithelial cohesion.
@en
Deregulated hepsin protease ac ...... isrupting epithelial cohesion.
@nl
P2093
P2860
P50
P356
P1433
P1476
Deregulated hepsin protease ac ...... disrupting epithelial cohesion
@en
P2093
A Moilanen
D Belitškin
H Ala-Hongisto
J Klefström
K Hewitson
L Nevalaita
M Leidenius
M Ramachandra
P E Kovanen
P2860
P2888
P304
P356
10.1038/ONC.2015.248
P407
P577
2015-07-13T00:00:00Z